Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model.
Eur Respir J
; 58(3)2021 09.
Article
in En
| MEDLINE
| ID: mdl-33574078
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tuberculosis, Pulmonary
/
Tuberculosis, Multidrug-Resistant
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
Eur Respir J
Year:
2021
Type:
Article
Affiliation country:
Germany